Current

Ministry of Health Regulates Certain Pharmaceutical and Cosmetic Products

Newsletter #161

On December 6, 2023, Ministerial Agreement No. 357-2023 was published, by which the Ministry of Public Health and Social Assistance (MSPAS) issued the Technical Standard for the Regulation of Distribution and Commercialization of Pharmaceutical and Related Products for Aesthetic Use in Authorized Establishments.

The list of products covered by this agreement includes the following:

  • Botulinum toxin type A
  • Linear hyaluronic acid
  • Cross-linked hyaluronic acid
  • Calcium hydroxyapatite
  • Polylactic acid dermal threads
  • Polydioxanone dermal threads
  • Polylactic polycaprolactone acid

 

The provisions established in the agreement will be applicable to distributors and drugstores that commercialize and distribute pharmaceutical products and related products for aesthetic use in authorized establishments in the country.

According to these regulations, distributors and drugstores may only sell the listed products to authorized establishments that have a health license issued by the Department of Regulation, Accreditation and Control of Health Establishments of the MSPAS. Therefore, it is prohibited to sell these products to individuals, beauty salons, spas, or other unauthorized establishments. 

Distributors and drugstores must have the appropriate support for the sale of products authorized by the MSPAS. This will be verified by the commercialization Kardex, which may be in physical or digital form.

The agreement has already entered into force and is available on the Ministry of Health's website at https://medicamentos.mspas.gob.gt/index.php/legislacion-vigente/acuerdos.

For more information, please contact:

SHARE
RELATED PUBLICATIONS

2025 Lessons for Great Results

We often hear the phrase "where there's a will, there's a way." Some even say that if you want something badly enough, it will come true. In a world that is so complex and often hopeless, it never hurts to have this kind of positive thinking to try to achieve great things. But objectively, reality often shows us that more elements are needed for the goals we set ourselves to become reality. Often, we even believe that we have done everything right, and yet we still don’t reach the goal.

Ver más

Organizational Maturity to Implement New Technologies

El auge de la Inteligencia Artificial (IA) es un fenómeno innegable. Hace apenas tres años que la IA generativa comenzó a sonar, y de acuerdo con la última encuesta de McKinsey, cuando termine 2025, el 88% de las organizaciones utilizarán IA para realizar al menos una función operativa.

Ver más

Guatemala Fast Tracks Patents Under the USPTO

On November 3, 2025, the Accelerated Patent Grant Agreement (APG) signed between the Guatemalan Intellectual Property Registry (RPI) and the United States Patent and Trademark Office (USPTO) came into force. It will be in effect for five years, with the possibility of revision or termination upon prior notice.

Ver más